Cannabis News
AI to Create New Weed Strains?
Published
6 days agoon
By
admin
Science Based Weed Strains: GSD”
After decades of writing about cannabis, I’ve become increasingly convinced that we’ve only scratched the surface of what this miraculous plant can offer humanity. While most folks are familiar with THC and CBD, the cannabis plant contains hundreds of compounds that interact with our bodies in fascinating and complex ways. We’re like children playing with blocks, just beginning to understand the intricate architecture possible when these compounds work in concert.
Think about it – there are over 100 known cannabinoids, more than 150 terpenes, and countless other bioactive compounds in cannabis. The potential combinations are staggering, and each could potentially produce unique effects. As our understanding of these mechanisms deepens, we’re approaching an era where we can design cannabis strains for specific purposes, much like a master perfumer blending scents or a pharmaceutical researcher developing targeted medications.
This isn’t just theoretical anymore. Earlier this year, I caught wind of something that perfectly illustrates this potential – a groundbreaking new strain called “Get Sh!t Done” (GSD). What caught my attention wasn’t just its clever name, but its impressive THCV content – a lesser-known cannabinoid that’s typically found in trace amounts. The developers claim they’ve created something remarkable: a strain that provides energy and focus without the traditional downsides of cannabis use like fatigue, mental fog, or the dreaded munchies.
As someone who’s watched countless strains come and go, often accompanied by grandiose marketing claims, I’ll admit I was skeptical at first. But this one’s different – it’s backed by actual clinical research and reproducible results. Let’s take a deeper look at what makes this strain so special and what it might mean for the future of cannabis development.
When Natural Natural announced they’d developed a strain containing 15-20% THCV, it raised more than a few eyebrows in the cannabis community. For context, most strains contain only trace amounts of THCV, typically less than 1%. Creating a strain with these levels while maintaining an 8-week flowering time is nothing short of revolutionary.
But what exactly makes THCV special? While its molecular structure closely resembles THC, THCV interacts with our endocannabinoid system in profoundly different ways. Think of THC as a key that fully opens a lock – in this case, the CB1 receptor in our brain. THCV, on the other hand, acts more like a dimmer switch. At lower doses, it can actually block these receptors, while at higher doses it activates them differently than THC does. This unique interaction explains why THCV doesn’t cause the typical “stoner” effects we associate with cannabis.
The real game-changer here is the clinical validation. Natural Natural didn’t just breed a high-THCV strain and call it a day – they put it to the test. In their IRB-backed study, they found some fascinating results. Users of GSD reported 20% higher energy levels compared to control groups, and perhaps most interestingly, those who consumed traditional THC-only products reported feeling fatigued approximately three times more often than the GSD group. As someone who’s written extensively about cannabis research, I can tell you that this kind of clinical validation is unfortunately rare in our industry.
Whitney Conroy from Natural Natural shared some insights with me that I found particularly intriguing. “THCV interacts with receptors in the brain differently. It is not impairing like THC. One study showed that THCV can improve response time in tests of impairment.” This challenges the traditional narrative about cannabis use and cognitive function.
What excites me most about GSD isn’t just what it does, but what it represents for the future of cannabis development. As Conroy explains, “We believe that the cannabis plant has endless opportunities… Breeding over the past 60 years has focused on THC potency. We believe it is time to move Beyond THC and bring back this diversity of chemistry to harness the power of cannabis truly.”
I couldn’t agree more. For too long, the cannabis industry has been fixated on THC percentages, treating them like the alcohol content of beer. But cannabis isn’t alcohol – it’s infinitely more complex and nuanced. GSD represents a shift toward purposeful breeding, where strains are developed not just to get users high, but to produce specific, beneficial effects.
The success of GSD suggests we’re entering a new era of cannabis development, where science, not marketing, leads the way. And if this is just the beginning, I can’t wait to see what comes next.
Having spent years observing and writing about the cannabis industry, I’ve developed some strong opinions about where we’re headed. In my view, we’re witnessing the early stages of a major transformation that will eventually split cannabis into three distinct categories: Recreational, Medical, and Industrial. While these categories technically exist today, the lines between them will become much sharper and more defined in the coming years.
The medical segment particularly fascinates me. I believe we’ll see it evolve away from the familiar “smoke your medicine” approach that currently dominates the market. Let’s be honest – while smoking flower might be enjoyable, it’s not the most efficient or precise way to deliver medical benefits. The development of strains like GSD points toward a future where medicinal cannabis more closely resembles traditional pharmaceuticals or supplements, with precise dosing and specific, targeted effects.
Industrial hemp is already carving out its own niche in the American economy, and I expect this trend to accelerate. From sustainable building materials to biodegradable plastics, the applications seem endless. But it’s the recreational market where I anticipate the most interesting developments.
The emergence of strains like GSD suggests we’re moving beyond the simple paradigm of “getting high” toward something more nuanced and purposeful. I envision a future where recreational cannabis splits into two main branches: classic recreational experiences (what we typically think of as getting high) and what I call “functional enhancement” – strains specifically designed to complement different activities and states of mind.
Imagine walking into a dispensary and finding joints specifically designed for different experiences: one for creative work, another for social situations, maybe even one for physical exercise. It’s not just about getting high anymore; it’s about choosing the exact kind of experience you want. The success of GSD’s THCV-dominant profile shows there’s already a market for this kind of targeted effect.
However – and this is a big however – all of this potential remains somewhat constrained by federal prohibition. The current legal landscape is like trying to run a marathon with your shoelaces tied together. The inability to conduct unrestricted research, move products across state lines, or access traditional banking services continues to hold back innovation. Just imagine what companies like Natural Natural could achieve if they had the same freedom to research and develop as other industries.
Despite these challenges, I remain optimistic. The cannabis industry has shown remarkable resilience and creativity even under restrictive conditions. When – not if – federal legalization finally arrives, I believe we’ll see an explosion of innovation that will transform cannabis in ways we can barely imagine today. The cannabis industry of 2030 might be as different from today as today’s legal market is from the underground scene of the 1990s.
One thing’s for certain – we’re living through a fascinating period in cannabis history, and developments like GSD are just the beginning. The future of cannabis isn’t just bright; it’s technicolor.
After spending considerable time analyzing GSD and its implications for the cannabis industry, one thing has become crystal clear to me – we’ve entered a new era of cannabis development. The introduction of scientifically-backed, purpose-bred strains like GSD isn’t just another product launch; it’s a paradigm shift in how we approach cannabis cultivation and development.
When I think back to my early days writing about cannabis, most conversations centered around THC percentages and whether indicas or sativas produced better highs. Now, we’re discussing clinical trials, specific cannabinoid ratios, and targeted effects. It’s like watching a garage band evolve into a symphony orchestra – same basic elements, but infinitely more sophisticated.
As cannabis laws continue to relax (and trust me, they will), we’ll see an influx of bright minds and serious innovation in this space. Combine this with the exponential learning capabilities of AI and advanced genetic research tools, and the potential becomes staggering. We’re talking about new medicines that could revolutionize mental health treatment, recreational products that enhance rather than impair, and industrial applications we haven’t even dreamed of yet.
It’s wild to think that less than a century ago, “Reefer Madness” propaganda was convincing people that cannabis would turn them into murderous fiends. Now, we’re developing strains that help people focus and get work done. The irony isn’t lost on me.
We’re living through what future historians will likely consider the renaissance of cannabis. The development of strains like GSD is just the beginning. As someone who’s dedicated their career to understanding and writing about this remarkable plant, I can tell you – the best is yet to come. Stay tuned, fellow enthusiasts. The cannabis story is just getting good.
NEW CANNABIS STRAIN INFO, READ ON…
You may like
Cannabis News
What are Mushroom Drops? – A Guide to Mushroom Tinctures and Extracts
Published
10 hours agoon
December 18, 2024By
admin
Mushroom drops, often referred to as mushroom tinctures or extracts, have gained significant popularity in recent years due to their potential health benefits. These liquid extracts harness the power of medicinal mushrooms, which have been used for centuries in traditional medicine systems around the world. This comprehensive guide will explore what mushroom drops are, their benefits, how they are made, the different types of mushrooms used, and how to choose the right product for your needs.
What Are Mushroom Drops?
Mushroom drops are concentrated liquid extracts derived from various species of mushrooms known for their medicinal properties. They are typically made using a dual extraction process that combines alcohol and water to extract the beneficial compounds found in mushrooms. This results in a potent tincture that can be easily consumed and absorbed by the body.
The History of Medicinal Mushrooms
The use of mushrooms for medicinal purposes dates back thousands of years. In Traditional Chinese Medicine (TCM), mushrooms like Reishi (Ganoderma lucidum) have been revered as “herbs of immortality” and are believed to promote longevity and health. Similarly, in other cultures, such as those in Japan and Native American traditions, various mushrooms have been used for their healing properties.
Benefits of Mushroom Drops
Mushroom drops offer a range of health benefits due to the bioactive compounds they contain. Here are some of the most notable benefits:
1. Immune Support
Many medicinal mushrooms are known to enhance immune function. For instance, Turkey Tail (Trametes versicolor) contains polysaccharopeptides (PSP) that stimulate immune response and may help fight infections.
2. Cognitive Enhancement
Lion’s Mane (Hericium erinaceus) is renowned for its neuroprotective properties. Studies suggest it may promote nerve growth factor (NGF) production, potentially improving cognitive function and memory.
3. Stress Relief and Mood Enhancement
Reishi is often called the “mushroom of immortality” and is known for its adaptogenic properties, helping the body cope with stress and promoting relaxation.
4. Antioxidant Properties
Mushrooms like Chaga (Inonotus obliquus) are rich in antioxidants, which help combat oxidative stress in the body, potentially reducing the risk of chronic diseases.
5. Anti-Inflammatory Effects
Many medicinal mushrooms exhibit anti-inflammatory properties. For example, Cordyceps has been shown to reduce inflammation and improve energy levels.
How Are Mushroom Drops Made?
The preparation of mushroom drops involves a careful extraction process to ensure that the beneficial compounds are effectively captured. The most common method is dual extraction:
Step 1: Sourcing Quality Mushrooms
The first step in making mushroom drops is sourcing high-quality mushrooms. Look for organic varieties that are sustainably harvested to ensure purity and potency.
Step 2: Drying the Mushrooms
Once harvested, mushrooms are typically dried to preserve their active compounds. This also makes them easier to work with during extraction.
Step 3: Alcohol Extraction
The dried mushrooms are soaked in high-proof alcohol (usually ethanol) for a specified period. This process extracts alcohol-soluble compounds such as triterpenes and other beneficial phytochemicals.
Step 4: Water Extraction
After the alcohol extraction, the mushroom material is then boiled in water. This step extracts water-soluble compounds like polysaccharides, which are crucial for immune support.
Step 5: Combining Extracts
The final step involves combining both extracts into a single tincture. This dual extraction method ensures a broad spectrum of beneficial compounds is available in each drop.
Different Types of Medicinal Mushrooms Used in Drops
There are numerous types of medicinal mushrooms that can be used in drops, each offering unique health benefits:
1. Reishi (Ganoderma lucidum)
Benefits: Known for its calming effects, Reishi is often used to reduce stress and improve sleep quality.
Active Compounds: Triterpenes, polysaccharides.
2. Lion’s Mane (Hericium erinaceus)
Benefits: Promotes cognitive function and nerve health.
Active Compounds: Hericenones, erinacines.
3. Turkey Tail (Trametes versicolor)
Benefits: Supports immune function and gut health.
Active Compounds: Polysaccharide K (PSK), polysaccharopeptides (PSP).
4. Chaga (Inonotus obliquus)
Benefits: Rich in antioxidants; supports overall health.
Active Compounds: Betulinic acid, polysaccharides.
5. Cordyceps (Cordyceps sinensis)
Benefits: Enhances energy levels and athletic performance.
Active Compounds: Cordycepin, adenosine.
Methods of Consumption
Mushroom drops can be taken in several ways:
-
Mixed with Water or Juice: Add drops to a glass of water or juice if you prefer not to take them directly.
-
In Smoothies or Foods: Incorporate into smoothies or recipes for added nutrition.
Choosing High-Quality Mushroom Drops
With the increasing popularity of mushroom supplements comes a variety of products on the market. Here’s how to choose high-quality mushroom drops:
1. Check Ingredients
Look for products that contain pure mushroom extracts without fillers or additives like rice flour or mycelium unless specified as part of the formulation.
2. Look for Dual Extraction
Ensure that the product specifies a dual extraction process on its label; this indicates that both alcohol-soluble and water-soluble compounds have been extracted.
3. Source Transparency
Choose brands that provide information about sourcing practices and quality control measures to ensure you’re getting a safe product.
4. Third-party Testing
Opt for products that have undergone third-party testing for potency and purity; this adds an extra layer of assurance regarding quality.
Potential Side Effects and Considerations
While mushroom drops are generally considered safe for most people when taken as directed, there are some considerations:
Some individuals may be allergic to certain types of mushrooms; if you have known allergies, consult with a healthcare provider before use.
Medicinal mushrooms can interact with certain medications, especially immunosuppressants or anticoagulants. Always consult with a healthcare professional if you are on medication or have underlying health conditions.
Consult your healthcare provider before using mushroom drops if you are pregnant or breastfeeding due to limited research on safety during these periods.
Conclusion
Mushroom drops offer a convenient way to harness the numerous health benefits associated with medicinal mushrooms. From immune support to cognitive enhancement, these potent extracts can be an excellent addition to your wellness routine. By understanding how they are made, their benefits, appropriate dosages, and how to choose high-quality products, you can make informed decisions about incorporating mushroom drops into your life.
As always, it’s essential to listen to your body and consult with healthcare professionals when making changes to your health regimen. With proper use and understanding, mushroom drops can be a valuable ally on your journey toward better health and well-being!
MAGIC MUSHROOM CHOCOLATES, READ ON…
Cannabis News
No Recreational Cannabis in Costa Rica
Published
1 day agoon
December 17, 2024By
admin
On November 28, 2024, the Costa Rican Constitutional Court, known as Sala IV, made a landmark ruling that has sent shockwaves through the nation and the broader Latin American region: it struck down a proposed referendum aimed at legalizing recreational cannabis. This decision not only halts the immediate efforts to bring recreational cannabis to the ballot but also raises critical questions about the future of cannabis legislation in a country that has seen significant strides in medical marijuana and hemp legislation. This article explores the implications of this ruling, the broader context of cannabis laws in Costa Rica, and what this means for future legislative efforts.
The Constitutional Court’s Ruling
Legal Basis for the Decision
The ruling by Sala IV was grounded in constitutional law and international obligations. The court found that the proposed referendum, which sought to allow Costa Ricans to vote on legalizing recreational cannabis, was unconstitutional based on Article 7 of Costa Rica’s Political Constitution. This article emphasizes that international treaties ratified by Costa Rica take precedence over domestic laws.
The court specifically cited conflicts with several key international agreements:
1. 1961 Single Convention on Narcotic Drugs: This treaty classifies cannabis as a controlled substance and restricts its use to medical and scientific purposes.
2. 1988 UN Convention Against Illicit Traffic in Narcotic Drugs: This agreement reinforces prohibitions against recreational use of drugs, including cannabis.
3. Vienna Convention on Psychotropic Substances: Like the previous treaties, this convention emphasizes restrictions on drug use and trafficking.
The court concluded that any attempt to legalize recreational cannabis through a referendum would violate these international obligations, thus rendering such a measure unconstitutional.
Background of the Proposed Referendum
The initiative for the referendum was led by Erick González Camacho, who sought to gather enough signatures to bring the issue before voters nationwide. The proposal aimed not only to legalize recreational cannabis but also to regulate its production and sale, similar to frameworks established in other countries that have embraced legalization.
The Supreme Electoral Tribunal (TSE) had initially referred González’s request for a referendum to the Constitutional Chamber for review. However, the court’s decision effectively blocks any progress of the bill through both the referendum mechanism and legislative approval without addressing these international conflicts.
The Broader Context of Cannabis Legislation in Costa Rica
While recreational cannabis remains illegal, Costa Rica has made significant strides in legalizing medical marijuana. In 2022, after extensive debate and advocacy from various sectors of society, Costa Rica legalized medical cannabis. This landmark decision allowed patients suffering from various ailments—including chronic pain, epilepsy, and cancer—to access therapeutic products derived from cannabis.
The legalization of medical marijuana marked a significant shift in public policy and social attitudes toward cannabis. It aligned Costa Rica with other Latin American countries that have recognized the medicinal benefits of cannabis while also providing a framework for regulation and oversight.
Moreover, Costa Rica has embraced industrial hemp cultivation as part of its agricultural strategy. The Ministry of Agriculture and Livestock (MAG) has issued numerous licenses for hemp production, signaling a growing acceptance of cannabis-related industries within regulated frameworks. Hemp is seen as a versatile crop with applications ranging from textiles to construction materials.
President Rodrigo Chaves’ Stance
President Rodrigo Chaves has been an outspoken advocate for legalizing recreational cannabis as part of his broader strategy to combat crime and generate tax revenue. Chaves argues that regulating cannabis could provide safe access for consumers while cutting off profits to criminal networks that thrive on illegal drug trade.
In his administration’s view, legalization could also yield significant economic benefits:
-
Tax Revenue: Legalizing recreational cannabis could generate substantial tax revenue that could be reinvested into public services such as healthcare and education.
-
Job Creation: A regulated cannabis market could create jobs across various sectors—from cultivation and retail to distribution and marketing.
-
Tourism: Legalization could attract tourists interested in experiencing a regulated cannabis market similar to those found in countries like Canada and certain U.S. states.
Despite these arguments, public opinion remains divided. Critics express concerns about potential increases in cannabis use among young people and emphasize adherence to international commitments as paramount. The ruling by Sala IV reflects these tensions between progressive policy initiatives and conservative legal frameworks.
Implications of the Court’s Decision
The court’s ruling signifies a substantial setback for advocates seeking to expand cannabis legalization in Costa Rica. It raises critical questions about how future legislation can navigate international obligations while addressing domestic desires for reform. For any new proposals to move forward, they would need to either align with existing treaties or involve a significant shift in Costa Rica’s approach to its international commitments.
In light of this ruling, lawmakers may consider several strategies:
1. Amendment of International Treaties: One potential avenue is advocating for changes at an international level regarding how treaties classify cannabis. However, this is a long-term strategy that would require cooperation from multiple countries.
2. Focus on Medical Cannabis Expansion: Given the court’s acceptance of medical marijuana legislation, advocates may shift their focus toward expanding access to medical products rather than pursuing recreational legalization at this time.
3. Public Education Campaigns: Educating the public about the potential benefits of legalization may help shift public opinion over time, creating an environment more conducive to future legislative efforts.
Public Response and Ongoing Debate
The ruling has reignited discussions around cannabis policy in Costa Rica. Advocates like González remain hopeful for future changes despite this setback; they argue that public sentiment is shifting toward acceptance of recreational use as societal attitudes evolve.
On social media platforms and community forums, citizens are expressing their views—both pro and con—regarding the ruling:
This ongoing debate highlights the complexities surrounding drug policy reform in Costa Rica, a nation known for its progressive social policies yet bound by traditional views on drug use.
The Economic Implications of Cannabis Legislation
While opponents often cite health risks associated with increased drug use as reasons against legalization, proponents highlight several economic benefits:
1. Tax Revenue Generation: Legalizing recreational cannabis could lead to substantial tax revenues that could be allocated toward public services such as education, healthcare, infrastructure development, and drug prevention programs.
2. Job Creation: A regulated market would create numerous jobs across various sectors cultivation, distribution, retail sales and stimulate local economies.
3. Tourism Growth: Countries like Canada have seen increased tourism due to their legalized cannabis markets; Costa Rica could potentially capitalize on this trend by attracting tourists interested in exploring its regulated market.
4. Reduction in Law Enforcement Costs: Legalization may lead to decreased law enforcement costs associated with prosecuting non-violent drug offenses related to possession or use of small amounts of cannabis.
Challenges Facing Economic Arguments
Despite these potential benefits, there are challenges facing advocates who wish to frame legalization as an economic necessity:
-
Concerns Over Public Health: Opponents argue that increased access may lead to higher rates of substance abuse among vulnerable populations.
-
International Obligations: As noted earlier, adherence to international treaties complicates any movement toward legalization; failure to comply could result in diplomatic repercussions or sanctions from other nations or organizations.
The Role of International Treaties
Costa Rica’s obligations under international treaties significantly impact its domestic drug policies:
1. Single Convention on Narcotic Drugs (1961): This treaty aims to combat drug abuse by controlling narcotics through strict regulations; it classifies many substances—including cannabis—as controlled drugs.
2. UN Convention Against Illicit Traffic in Narcotic Drugs (1988): This treaty emphasizes collaboration among nations to combat drug trafficking while reinforcing prohibitions against certain substances’ recreational use.
3. Vienna Convention on Psychotropic Substances (1971): Similar in nature to previous treaties but focuses more specifically on psychotropic substances rather than narcotics alone.
These treaties create a framework within which countries must operate regarding drug policy; thus far, they have largely reinforced prohibitionist approaches globally.
The Need for Reform at an International Level
Advocates for reform argue that existing international treaties are outdated given evolving scientific understandings regarding cannabinoids’ therapeutic properties:
Conclusion
Costa Rica is currently at a pivotal moment in its cannabis legislation following the Constitutional Court’s recent ruling against a proposed referendum for recreational use. This decision highlights the intricate balance between international treaties and domestic reform aspirations, a challenge that many nations face in addressing drug policy. Despite advancements in medical marijuana access and industrial hemp cultivation, the issue of recreational cannabis remains contentious and fraught with legal hurdles. Advocates continue to push for change, fueled by hope that public education campaigns and potential legislative reforms will eventually lead to responsible regulation rather than the historical prohibitionist approaches prevalent in Latin America. Navigating this complex landscape will require lawmakers to engage thoughtfully with constituents, striving to create equitable policies that honor both national interests and international commitments as Costa Rica moves forward into an uncertain yet promising future regarding cannabis use.
COSTA RICA AND CANNABIS, READ ON…
Cannabis News
Fibromyalgia Patients Enjoy Long Term Benefits After Cannabis Medication Says New Medical Study
Published
2 days agoon
December 16, 2024By
admin
Growing Number Of Studies Back Up Efficacy Of Weed For Fibromyalgia
Fibromyalgia is a chronic condition notorious for being so difficult to treat.
Patients with fibromyalgia struggle with pain throughout the body, particularly affecting the musculoskeletal system. It’s also characterized by other symptoms including sleep and memory issues, fatigue, and mood swings.
Fibromyalgia, being chronic in nature, takes an extremely long time to manage. There is no cure for this disease, but patients are often prescribed a cocktail of medications and are recommended to undergo serious lifestyle changes and therapy sessions to help.
Aside from numerous painkillers, anti-seizure drugs, and antidepressants, fibromyalgia patients greatly benefit from physical therapy, cognitive-behavioral therapy, exercise, and various stress management techniques. While it can be months, or even years, for patients to experience relief, scientists haven’t stopped working to discover better treatment modalities for this condition.
And thankfully, cannabis has shown to be one of them.
Legal marijuana is now giving fibromyalgia patients hope to regain control and quality of their life again. There is a growing number of studies supporting the benefits of weed for fibromyalgia. In one of the latest studies out of London, researchers analyzed the efficacy of cannabis-based medicinal products (CBMPs) which were either oil extracts or flower, on 148 fibromyalgia patients from the UK Medical Cannabis Registry. As is the standard for patients in the United Kingdom who are enrolled in the UK Medical Cannabis Registry, these patients have been unresponsive to traditional medications.
Yet, after being treated with cannabis, the patients reported improvements at various intervals, namely 1, 3, and 6 months after. “Improvements in the generalized anxiety disorder-7 questionnaire, single-item sleep quality scale, fibromyalgia symptom severity score and EQ-5D-5L Index values were observed at each follow up period compared to baseline,” said the researchers. They added that the participants reported significant reductions in their dependence of prescription opioids during the time of the study. However, they did experience dry mouth, headache, and some fatigue.
“Positive associations between initiation of CBMP therapy and decreased fibromyalgia severity were observed at all time points…” concluded the authors. “These findings are complemented by wider literature,” they wrote.
Meanwhile, another recent study from Colombia analyzed how various cannabis preparations impacted the symptoms of patients with fibromyalgia syndrome, also known as FMS. To achieve this, an international team of researchers pored through data taken from 14 clinical studies as well as 5 review papers. According to their findings, cannabis products were effective in reducing pain and other symptoms, while keeping side effects to a minimum.
They concluded that cannabis products “can improve musculoskeletal, somatic, and psychiatric symptoms in patients with FMS, mainly pain, fatigue, and depression; also, these products could be considered as safe,” they wrote.
Another study from 2022 found that cannabis was effective, especially in helping women who were suffering from treatment-resistant fibromyalgia. For this study, researchers utilized the World Health Organization Quality of Life Bref questionnaire to gauge the quality of life of 30 female fibromyalgia patients, whose ages ranged from 18 to 70 years.
Given they were all treatment-resistant cases, they already exhausted all conventional pharmacological fibromyalgia treatment. The questionnaire focused on four aspects: psychological health, social relationships, environment, and physical health. The women were asked to fill up the questionnaire before medicating with cannabis, then again a month after. They were asked to choose their preferred way to medicate: whether they ingest, smoke, or vaporize, it was up to them.
During follow-up sessions, the researchers found that the treatment contributed to an improvement in general quality of life, activities of daily living, general health, psychological health, physical health, pain and discomfort. Th patients also reported seeing positive changes that affected aspects of fatigue, pain, self-esteem, memory, and positive feelings as a whole.
Conclusion
It’s no surprise there’s a growing interest in using cannabis for fibromyalgia. Cannabis works so well for this condition because of the way it interacts with the endocannabinoid system. After all, the human endocannabinoid system is responsible for regulating pain as well as so many other important functions in the body.
Since pain is a hallmark symptom of fibromyalgia, patients who medicate with marijuana find tremendous relief. Even better, many cannabis medications such as edibles provide long-lasting pain relief without the addictive and harmful effects of opioids and other conventional medications. In addition, the pain caused by fibromyalgia can make it difficult to sleep and rest well. Cannabis also has a multitude of other benefits for fibromyalgia patients, including its ability to fight inflammation, regulate moods, and improve sleep.
There’s a great variety of weed products in the market that can help alleviate pain and reduce symptoms. From edibles to oils and tinctures, there’s a medication out there for everyone. Edibles are preferred for pain patients in general, because it provides longer-lasting relief from many different types of pain. However, capsules and tinctures allow patients to enjoy more control over dosing. When it comes to choosing whether to take CBD or THC, many patients find relief when consuming a product with a combination of both cannabinoids. Excessively high THC may not be suitable for older patients or those that need to focus, so getting one with a good balance of both or is CBD dominant may be ideal.
Speak to your doctor if you’d like to include cannabis therapies to target fibromyalgia symptoms. Healthcare providers with experience in marijuana medication can also provide valuable advice.
WHAT THC CAN DO FOR FIBROMYAGIA, READ ON…
WHAT DOES THC DO FOR FIBRYOMYAGLIA PATIENTS? READ THIS!
How To Make Cannabis Hashish
The Best Tips If You Are Giving Marijuana As A Gift
What are Mushroom Drops? – A Guide to Mushroom Tinctures and Extracts
Not Everyone Has A Happy Holiday But Maybe Marijuana Can Help
Frosty The SnowMan’s Life Lessons
The Best Holiday Whiskey Cocktails
Vendors Offering High-Potency Kratom: What You Need to Know
PornHub Reveals What People Watched In 2024
No Recreational Cannabis in Costa Rica
Ohio adult-use program was only new marijuana market launch in 2024
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing12 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse